Back to Agenda
Session 4: Innovative Trial Designs with Information Borrowing Including Basket Trials
Session Chair(s)
Michelle Detry, PhD
Director, Adaptive Trial Execution & Senior Statistical Scientist
Berry Consultants LLC, United States
Yi Liu, PhD
Vice President, Biometrics
Nektar Therapeutics, United States
This session will highlight innovations in clinical trial design where information is borrowed or shared in the primary trial analyses. Examples will include sharing of information from within a trial, e.g. Basket Trials, or borrowing of information external to the trial. The use of information borrowing in trial design requires thoughtful consideration not only regarding which information that is shared or borrowed and the amount of borrowing, but also the statistical adjustments that need to be considered to ensure trial results are scientifically valid and accepted by the scientific community and regulatory authorities. Case studies with information borrowing or sharing, both internal and external to a trial, will be presented.
Learning Objective : - Outline why information borrowing may be considered and included in trial designs and the resulting potential benefits/efficiencies towards answering the trial question
- Describe considerations and statistical adjustments that need to be implemented when borrowing of information is included in a trial design
- Identify multiple clinical trial designs where information borrowing through internal sharing, or external borrowing, was a key design component
Speaker(s)
Utilizing Real-World Data (RWD) to Inform a Confirmatory Basket Trial (CBT) Design: Studying Use of Rituximab in Autoimmune Diseases
Robert A. Beckman, MD
Georgetown University Medical Center, United States
Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics
Borrowing Phase 2 Data in Phase 3: The PUNCH CD3 Trial
Joe Marion, PhD
Berry Consultants, United States
Senior Statistical Scientist
NEOS: An Innovative Bayesian Non-inferiority Trial Design in Pediatric Multiple Sclerosis
Dieter Adrian Haering, DrSc, PhD
Novartis, Switzerland
Senior Director Biostatistics
Have an account?